24/7 Market News Snapshot 28 October, 2024 – Genprex, Inc. Common Stock (NASDAQ:GNPX)

October 28, 2024

DENVER, Colo., 28 October, 2024 (247marketnews.com) – (NASDAQ:GNPX) are discussed in this article.
Genprex, Inc. has recently experienced a notable surge in its stock performance, with shares opening at $2.03 and climbing to $2.53, marking an impressive increase of nearly 28%. This surge comes after a previous closing of $1.98, reflecting strong investor interest and trading volume, which has reached approximately 4.32 million shares. As the stock continues to gain momentum, potential resistance levels are identified around $2.60, signaling further bullish sentiment in the market.

In addition to this positive market response, Genprex has made significant strides in advancing its innovative lead drug candidate, Reqorsa® Gene Therapy (quaratusugene ozeplasmid), which targets challenging cancers such as lung cancer, mesothelioma, and glioblastoma. Recent preclinical findings were showcased at the 2024 EORTC-NCI-AACR Symposium, focusing on the drug’s potential efficacy against KRAS G12C mutant lung cancer. Ryan Confer, President and CEO of Genprex, expressed optimism about the results, highlighting the importance of expanding Reqorsa’s applications in areas where there is a substantial unmet medical need.

Further establishing its commitment to innovative cancer therapies, Genprex has filed two provisional patent applications concerning the use of Reqorsa for treating mesothelioma and glioblastoma, alongside collaborations with esteemed research institutions. In response to the critical need for advancements in oncology, the company has also established a Mesothelioma Clinical Advisory Board, comprising four leading experts dedicated to enhancing treatment strategies. The findings presented at the symposium include impactful research data, reinforcing Genprex’s mission to develop transformative treatments for patients facing dire health challenges. Full details of the presentations will be made available on Genprex’s website for those interested in exploring this promising research further.

Related news for (GNPX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.